Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H1GQ
|
|||
| Former ID |
DNC012989
|
|||
| Drug Name |
2-(3-benzylquinoxalin-2-ylamino)ethanol
|
|||
| Synonyms |
CHEMBL203892; 2-(3-benzylquinoxalin-2-ylamino)ethanol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H17N3O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N=C2NCCO
|
|||
| InChI |
1S/C17H17N3O/c21-11-10-18-17-16(12-13-6-2-1-3-7-13)19-14-8-4-5-9-15(14)20-17/h1-9,21H,10-12H2,(H,18,20)
|
|||
| InChIKey |
SNVOYVYEVPVVNG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.